New Antisense Technology Study Findings Have Been Reported by Researchers at Hebrew University

Here we show, using parthenogenetic induced pluripotent stem cells, an imprinted transcript that serves as an antisense regulator of onco-miR-372-3 ."

http://www.hispanicbusiness.com/2014/1/2/new_antisense_technology_study_findings_have.htm